Pfizer and biontech announce collaboration with biovac to manufacture and distribute covid-19 vaccine doses within africa

New york and mainz, germany, july 21, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced the signing of a letter of intent with the biovac institute (pty) ltd, known as “biovac”, a cape town-based, south african biopharmaceutical company, to manufacture the pfizer-biontech covid-19 vaccine for distribution within the african union.
BNTX Ratings Summary
BNTX Quant Ranking